Citation Impact
Citing Papers
Sunitinib-Induced Myeloid Lineage Redistribution in Renal Cell Cancer Patients: CD1c+ Dendritic Cell Frequency Predicts Progression-Free Survival
2008
Effector CD8+ T-cell Engraftment and Antitumor Immunity in Lymphodepleted Hosts Is IL7Rα Dependent
2015
Ferroptosis regulation by the NGLY1/NFE2L1 pathway
2022 StandoutNobel
Central Role of IFNγ–Indoleamine 2,3-Dioxygenase Axis in Regulation of Interleukin-12–Mediated Antitumor Immunity
2009
T cell recognition of HLA‐A2 restricted tumor antigens is impaired by the oncogene HER2
2010
Targeting the tumor vasculature to enhance T cell activity
2015
Hallmarks of Cancer: The Next Generation
2011 Standout
Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
2010 Standout
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Myeloid-derived suppressor cells coming of age
2018 Standout
Anoikis evasion in inflammatory breast cancer cells is mediated by Bim-EL sequestration
2014
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
2011 Nature
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Dendritic Cell-Derived Exosomes Promote Natural Killer Cell Activation and Proliferation: A Role for NKG2D Ligands and IL-15Rα
2009
Mechanism and medical implications of mammalian autophagy
2018 Standout
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
2012 Standout
Natural killer cell–directed therapies: moving from unexpected results to successful strategies
2008
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Deciphering and Reversing Tumor Immune Suppression
2013
Programmed death-1 blockade enhances expansion and functional capacity of human melanoma antigen-specific CTLs
2007
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Coordinated regulation of myeloid cells by tumours
2012 Standout
Control of the Immune Response by Pro-Angiogenic Factors
2014
Cancer immunotherapy via dendritic cells
2012 Standout
Hepatocellular carcinoma
2021 Standout
Interdependent IL-7 and IFN-γ signalling in T-cell controls tumour eradication by combined α-CTLA-4+α-PD-1 therapy
2016 StandoutNobel
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Membrane vesicles as conveyors of immune responses
2009 Standout
Turbocharging vaccines: emerging adjuvants for dendritic cell based therapeutic cancer vaccines
2017
Thermal ablation of tumours: biological mechanisms and advances in therapy
2014 Standout
Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa
2018
Corrupt policemen: inflammatory cells promote tumor angiogenesis
2008
Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion
2013 StandoutNobel
Combinations of Bevacizumab With Cancer Immunotherapy
2018
Strategies of Tumor Immune Evasion
2005
5-aminolevulinic acid-incorporated nanoparticles of methoxy poly(ethylene glycol)-chitosan copolymer for photodynamic therapy
2013
Tumor Microenvironment and Myeloid-Derived Suppressor Cells
2012
Taking dendritic cells into medicine
2007 StandoutNatureNobel
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
The Hippo Pathway Effector TAZ Regulates Ferroptosis in Renal Cell Carcinoma
2019
Dendritic-Cell-Based Therapeutic Cancer Vaccines
2013
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
2017 Standout
Cancer immunotherapy comes of age
2011 StandoutNature
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
Targeting ferroptosis as a vulnerability in cancer
2022 Standout
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
2013 Standout
Tumor cell expression of programmed cell death‐1 ligand 1 is a prognostic factor for malignant melanoma
2010 StandoutNobel
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
The secret ally: immunostimulation by anticancer drugs
2012
Immunotherapy for pancreatic cancer — science driving clinical progress
2005
Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients
2013
Inhibition of Immune Checkpoints and Vascular Endothelial Growth Factor as Combination Therapy for Metastatic Melanoma: An Overview of Rationale, Preclinical Evidence, and Initial Clinical Data
2015
Hypoxia Promotes Tumor Growth in Linking Angiogenesis to Immune Escape
2012
Cancer as an evolutionary and ecological process
2006 Standout
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner
2012 StandoutNobel
Dendritic cells integrate signals from the tumor microenvironment to modulate immunity and tumor growth
2009
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
2018 Standout
Antiangiogenic Agents Can Increase Lymphocyte Infiltration into Tumor and Enhance the Effectiveness of Adoptive Immunotherapy of Cancer
2010
Role of hypoxia in inhibiting dendritic cells by VEGF signaling in tumor microenvironments: mechanism and application.
2021
The Intersection between Tumor Angiogenesis and Immune Suppression
2019
Tumor-Associated Tn-MUC1 Glycoform Is Internalized through the Macrophage Galactose-Type C-Type Lectin and Delivered to the HLA Class I and II Compartments in Dendritic Cells
2007
Density Variant Glycan Microarray for Evaluating Cross-Linking of Mucin-like Glycoconjugates by Lectins
2012 StandoutNobel
Sensitivity of Dendritic Cells to Microenvironment Signals
2016
Normalization of the Vasculature for Treatment of Cancer and Other Diseases
2011
Dendritic cell immunotherapy: clinical outcomes
2014
Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans
2011 StandoutNobel
Cell intrinsic mechanisms of T‐cell inhibition and application to cancer therapy
2008 StandoutNobel
Nanoparticles in Photodynamic Therapy
2015 Standout
Anti-Angiogenics: Current Situation and Future Perspectives
2018
The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression
2016
CLEC12A-Mediated Antigen Uptake and Cross-Presentation by Human Dendritic Cell Subsets Efficiently Boost Tumor-Reactive T Cell Responses
2016
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Recent advances in polymeric materials for the delivery of RNA therapeutics
2019
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade
2017
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Vaccine adjuvant uses of poly-IC and derivatives
2014
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
2013 StandoutNobel
Targeting dendritic cells—why bother?
2013
PD-1 and Its Ligands in Tolerance and Immunity
2008 Standout
Innate or Adaptive Immunity? The Example of Natural Killer Cells
2011 StandoutScience
Immunogenic Cell Death in Cancer Therapy
2012 Standout
Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia
2015
Works of Timothy Clay being referenced
Phase I Study Utilizing a Novel Antigen-Presenting Cell–Targeted Vaccine with Toll-like Receptor Stimulation to Induce Immunity to Self-antigens in Cancer Patients
2011
Characterization of an Oxaliplatin Sensitivity Predictor in a Preclinical Murine Model of Colorectal Cancer
2012
Trastuzumab signaling in ErbB2-overexpressing inflammatory breast cancer correlates with X-linked inhibitor of apoptosis protein expression
2008
NK cell activation by dendritic cell vaccine: a mechanism of action for clinical activity
2005
Current Immunotherapeutic Strategies in Colon Cancer
2007
CD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced tumor targeting
2010
Physiology and Therapeutics of Vascular Endothelial Growth Factor in Tumor Immunosuppression
2009
The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients
2008
Recent developments in therapeutic cancer vaccines
2005
Phase I study of immunization with dendritic cells (DC) modified with recombinant fowlpox encoding carcinoembryonic antigen (CEA) and the triad of costimulatory molecules CD54, CD58, and CD80 (rF-CEA(6D)-TRICOM) in patients with advanced malignancies
2004
Phase I study of immunization with dendritic cells (DC) modified with recombinant fowlpox encoding carcinoembryonic antigen (CEA) and the triad of costimulatory molecules CD54, CD58, and CD80 (rF-CEA(6D)-TRICOM) in patients with advanced malignancies
2004